Skip to main content
Caplight Logo









Stimvia

Stimvia

Private
OstravaHealthcare & Life Scienceshttps://www.stimvia.com/

Last Round

Series A

Sep 18, 2023

Company Overview

Stimvia is a medical technology company that develops non-invasive neuromodulation systems for the treatment of chronic diseases such as overactive bladder and Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

neuromodulationmedical deviceoveractive bladderOABnon-invasive therapyurologybiofeedbackclosed-loop stimulationmedtechdigital healtheTNMelectrical stimulationhealth IoTsmart medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stimvia Comparables

Compare Stimvia with similar companies based on industry and business-model similarity.

Stimvia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EBT Medical
90%
Stimuli Technology
82%
Avation Medical
78%

Stimvia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 18, 2023
VC RoundJun 1, 2021
AngelJul 7, 2014

Stimvia Investors

Notable investors and investment history

Stimvia investors
InvestorRounds
Purple VenturesVC Round
Soulmates VenturesVC Round
Climate KICAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2021

    $4.6M round led by Purple Ventures and Soulmates Ventures.

Recent news

Latest coverage and updates

  • hiresOct 1, 2026

    Stimvia appoints Russ Mably as Chief Executive Officer on Oct 1st '26

  • promotesOct 1, 2026

    Stimvia plans to promote Lukas Doskocil to Founder and Chief Product Officer

Stimvia Filings

Explore SEC and related filing metadata, where available.

Stimvia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stimvia's valuation, stock price, and market status.

Is Stimvia a public or private company?

Stimvia is a private company.

What is the current stock price of Stimvia?

Stimvia is a private company, so its shares have no public market price. Caplight tracks Stimvia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Stimvia worth (valuation)?

Valuation information for Stimvia is not publicly available.

Can I buy Stimvia stock?

Stimvia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Stimvia's last funding round?

Stimvia's most recent funding round was Series A on September 18, 2023.

Who are the main investors in Stimvia?

Key investors in Stimvia include Purple Ventures, Soulmates Ventures, Climate KIC.

Will Stimvia IPO soon?

No public IPO plans have been announced for Stimvia.

How can I track Stimvia secondary market activity?

Caplight tracks bids, offers, and trades in Stimvia's shares on secondary markets.

Firmographic Details

HeadquartersOstrava
Year Founded2014
Last FundingSep 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?